Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Shanghai Stock Exchange  >  China National Medicines Corporation Ltd.    600511   CNE000001D56

CHINA NATIONAL MEDICINES CORPORATION LTD.

(600511)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Financials
Sales 2020 47 207 M 7 285 M 7 285 M
Net income 2020 1 700 M 262 M 262 M
Net Debt 2020 - - -
P/E ratio 2020 18,8x
Yield 2020 1,18%
Sales 2021 53 884 M 8 315 M 8 315 M
Net income 2021 1 950 M 301 M 301 M
Net Debt 2021 - - -
P/E ratio 2021 16,4x
Yield 2021 1,25%
Capitalization 31 983 M 4 936 M 4 936 M
Capi. / Sales 2020 0,68x
Capi. / Sales 2021 0,59x
Nbr of Employees -
Free-Float 40,9%
More Financials
Company
China National Medicines Corporation Ltd. is a China-based company principally engaged in the distribution of pharmaceutical products. The Company's primary products include proprietary Chinese medicines, chemical medicine preparations, chemical raw materials, antibiotics, biochemical drugs, biological products, narcotic drugs, psychotropic drugs, vaccines and health foods, among others. The Company is also involved... 
Read more
Sector
Drug Retailers
Calendar
03/19Earnings Release
More about the company
Notations Surperformance© of China National Medicines Corporation Ltd.
Trading Rating : Investor Rating :
More Ratings
All news about CHINA NATIONAL MEDICINES CORPORATION LTD.
2020CHINA NATIONAL MEDICINES : Sinopharm's COVID-19 Vaccine Gets Approval in China; ..
MT
2020CHINA NATIONAL MEDICINES CORPORATION : half-yearly earnings release
2020Hong Kong stocks rise over 2% as consumer firms rally; China up
RE
2020CHINA NATIONAL MEDICINES CORPORATION : annual earnings release
2019CHINA NATIONAL MEDICINES CORPORATION : annual earnings release
More news
News in other languages on CHINA NATIONAL MEDICINES CORPORATION LTD.
2020CHINA NATIONAL MEDICINES CORPORATION : Veröffentlichung des Halbjahresergebnisse..
2020CHINA NATIONAL MEDICINES CORPORATION : publication des résultats semestriels
2020CHINA NATIONAL MEDICINES CORPORATION : Veröffentlichung des Jahresergebnisses
2020CHINA NATIONAL MEDICINES CORPORATION : publication des résultats annuels
2019CHINA NATIONAL MEDICINES CORPORATION : Veröffentlichung des Jahresergebnisses
More news
Chart CHINA NATIONAL MEDICINES CORPORATION LTD.
Duration : Period :
China National Medicines Corporation Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHINA NATIONAL MEDICINES CORPORATION LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Average target price 48,00 CNY
Last Close Price 42,39 CNY
Spread / Highest target 13,2%
Spread / Average Target 13,2%
Spread / Lowest Target 13,2%
EPS Revisions
Managers and Directors
NameTitle
Hui Li General Manager & Director
Xiu Chang Jiang Chairman & Vice President
Jing Yun Liu Chairman-Supervisory Board
Li Xin Shen Chief Financial Officer
Peng Ren Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CHINA NATIONAL MEDICINES CORPORATION LTD.-14.03%4 936
WALGREENS BOOTS ALLIANCE, INC.23.67%42 269
MCKESSON CORPORATION6.04%29 611
CARDINAL HEALTH, INC.3.42%16 267
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.14.36%9 076
YIFENG PHARMACY CHAIN CO., LTD.10.21%8 154
Categories
Free services
Mobile App
SOLUTIONS
About
Stock Market Quotes Interactive brokers The best of tweets Stock Market News Börse: Aktien, Kurse und Nachrichten
Copyright © 2021 Surperformance. All rights reserved. Stock quotes are provided by Factset, Morningstar and S&P Capital IQ